Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

PEG-Intron A progresses to phase III for treatment of hepatitis C

Aug. 5, 1997

HCV virus isolated and cloned for the first time

Aug. 4, 1997

Mylan enters distribution agreement for ranitidine

July 29, 1997

Gastrointestinal role of GLP-1(7-36 amide) explored

July 28, 1997

Roberts seeks approval to begin clinical studies of gastrointestinal drug

July 24, 1997

Garlic suggested to merit further evaluation for H. pylori infections

July 24, 1997

Genome Therapeutics and Astra Research Center Boston extend H. pylori alliance

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Pylorid introduced in Argentina

July 22, 1997

Use of NK3 antagonists in various disorders claimed by SKB

July 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...